Evidence map›Paper›PMID 38639647›Full record

ArticleTherapeutic delivery2024

Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study.

Rehab M Abdel-Megeed, Hassan Z Ghanem, Mai O Kadry

Open access · greenAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic delivery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rehab M Abdel-MegeedTherapeutic Chemistry Department, Pharmaceutical & Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt.ORCID 0000-0001-8113-8834
Hassan Z GhanemTherapeutic Chemistry Department, Pharmaceutical & Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt.ORCID 0000-0002-0818-5738
Mai O KadryTherapeutic Chemistry Department, Pharmaceutical & Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt.
National Research Centre · EG

Funding

National Research Centre 12020206
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularDoxorubicinPolyethylene GlycolsAnimalsAntibiotics, AntineoplasticBiomarkers, TumorDrug Delivery SystemsDrug Resistance, NeoplasmHumansLactoferrinLiver NeoplasmsMaleTitaniumAntibiotics, AntineoplasticBiomarkers, TumorDoxorubicinLactoferrinliposomal doxorubicinPolyethylene GlycolsTitaniumtitanium dioxideC-mycEGFRHbrt-1Hepatocellular carcinomalactoferrin-doxorubicinPEGylated doxorubicintitanium dioxide-loaded doxorubicin

Identifiers

PMID38639647
PMCPMC11285276
OpenAlexW4394962107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.